NIPINEC
Showing 1 - 1 of 1
Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)
Active, not recruiting
- Neuroendocrine Carcinoma
-
Aix-en-Provence, France
- +6 more
Mar 9, 2022